Navigation Links
Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
Date:9/17/2008

BETHESDA, Md., Sept. 17 /PRNewswire-USNewswire/ -- Findings from a trial of the accuracy of CT colonography (CTC) compared to complete colonoscopy in detecting large pre-cancerous polyps and colorectal cancers, coordinated by the American College of Radiology Imaging Network (ACRIN), raise several important issues for the public about colorectal cancer screening using a CT scan of the abdomen: the potential need for follow-up with complete colonoscopy in many cases, the real risk of undetected and unreported smaller growths with pre-cancerous potential, the reality of radiation risks relating to CT scans, as well as questions regarding patient acceptability of this test.

"Today's findings underscore the reality that many patients who have polyps detected by CT colonography will still have to undergo complete colonoscopy," explained Dr. Amy Foxx-Orenstein, D.O., FACG, President of the American College of Gastroenterology. Researchers found that as many as 12 percent to 17 percent of study participants screened by CTC would have to be referred for complete colonoscopy depending on the size threshold for reporting lesions in the colon. Of more significant concern, is that the researchers only reported growths in the colon 5 mm or larger, leaving unreported and therefore undetected an untold number of potentially high risk pre-cancerous growths.

"The College sees significant strengths in the proven benefits of visualizing pre-cancerous growths and removing them in a single examination during colonoscopy," commented Dr. Foxx-Orenstein.

"There is a tremendous body of evidence that shows that clearing the colon of polyps, including small polyps, significantly reduces colorectal cancer mortality. Because of its excellent sensitivity in detecting polyps and its potential for removing them and breaking the sequence of polyp to cancer in a single diagnostic and therapeutic intervention, complete colonoscopy is one of the most powerful preventive too
'/>"/>

SOURCE American College of Gastroenterology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose
2. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery
3. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
4. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
5. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
6. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
7. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
8. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
9. Two New Alzheimers Disease Studies Show Advances Against Different Treatment Targets
10. Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
11. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Nov.24/PRNewswire-USNewswire/--America,spharmaceut...edicinesandvaccinestotreatorpreventHIV/AIDSandrela...thePharmaceuticalResearchandManufacturersofAmerica...DSDay"-aglobalawarenesscampaignthatoriginatedatthe...IDSPrevention. ,, "Wearegreatlyencouragedbythes...
(Date:11/24/2009)....24/PRNewswire-Asia-FirstCall/--LotusPharmaceutica...ny")agrowingdeveloperand,producerofprescriptionsdr...ctsinthePeople,sRepublicChina,todayreporteditwille...rmaceuticaldelegation. ,, Time:November26-28,...engdu ,, TheBeijingdelegationfeaturesmorethan...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--ZimmerHoldings,Inc....atinginthe21stAnnualPiperJaffrayHealthCareConferen...ternTime. ,, Alivewebcastofthepresentationcanbe...://investor.zimmer.com .Thewebcastwillbearchivedfo...any ,, Foundedin1927andheadquarteredinWarsaw,I...
Breaking Medicine Technology:New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2BET News Presents Critical Condition 3A Whats At Stake In Health Care Reform Sunday September 27 at 10 PM 58300 1BET News Presents Critical Condition 3A Whats At Stake In Health Care Reform Sunday September 27 at 10 PM 58300 2BET News Presents Critical Condition 3A Whats At Stake In Health Care Reform Sunday September 27 at 10 PM 58300 3H1N1 Flu 3A Are Parents Underestimating Risk to Kids 3F 58298 1H1N1 Flu 3A Are Parents Underestimating Risk to Kids 3F 58298 2H1N1 Flu 3A Are Parents Underestimating Risk to Kids 3F 58298 3H1N1 Flu 3A Are Parents Underestimating Risk to Kids 3F 58298 4Bioniche Pharma and Synerx Pharma Launch Fomepizole Injection 58296 1Bioniche Pharma and Synerx Pharma Launch Fomepizole Injection 58296 2
...resented at the Targeted,Anticancer Therapies (TAT... for Cancer Meetings Support Phase 1 Trial Design,...wswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc....stage compound, SNS-314, at,two leading scientific.... Findings from in vitro and in vivo studies demon...
...ON BETWEEN,PLASMA LEVELS AND CLINICAL OUTCOME ACHI...ference call and live,webcast on March 20, 2007 at...7) – Corcept Therapeutics,Incorporated (NASD... of three Phase 3 trials evaluating CORLUX for tre...pression (PMD), did not,achieve statistical signif...
Other Medicine Technology:Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 2Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 3Corcept Therapeutics Announces Phase 3 Study Evaluating Corlux for,Psychotic Major Depression Misses Primary Endpoint 2Corcept Therapeutics Announces Phase 3 Study Evaluating Corlux for,Psychotic Major Depression Misses Primary Endpoint 3Corcept Therapeutics Announces Phase 3 Study Evaluating Corlux for,Psychotic Major Depression Misses Primary Endpoint 4Corcept Therapeutics Announces Phase 3 Study Evaluating Corlux for,Psychotic Major Depression Misses Primary Endpoint 5
(Date:11/24/2009)...24/PRNewswire-FirstCall/-HardtoTreatDiseases(HTDS;...diarySlavicaBioChem,isprovidingthisbriefupdatetoit...uediligencewiththeEUstemcellcompanyandmergerdiscus...tOct29,2009whichthecompanymade. http://www.pinkshe... ,, HTDSandSlavicaBiochemarealsodiscussingonexp...
(Date:11/24/2009)...swire-USNewswire/--Thereisanewgameintownwhenitcome...feringpragmaticandrealisticstrategieswheretraditio...ingthismovementisagroupcalledHAMS--HarmReduction,A...f-charge,lay-ledsupportandinformationalgroupforpeo...coholAbuseandAlcoholismtellsusthatonly7%ofpeoplewi...
(Date:11/24/2009)...swire/--TheGuardianLifeInsuranceCompanyofAmerica(G...ingproviderofemployeebenefitsforsmallandmid-sizedc...ofollowitscurrentinsurancecoverageguidelinesformam...htheAmericanCancerSocietyandAmericanMedicalAssocia...,, Recently,TheU.S.PreventiveServicesTaskForcer...
(Date:11/24/2009)...USPSTFRepresentationandRecommendationProcess ,...alsectionsofSenatehealthcarereformlegislation cont...rivateinsurers,MedicareandMedicaidwouldonlyberequi...S.PreventativeServicesTaskForce.Presently,thiswoul...requirecoverageofbiennial(everyotheryear)coveragef...
(Date:11/24/2009)...r 24, 2009 Researchers at Ben-Gurion University o...ts cancerous skin tumors, including melanomas that...al testing, the OSPI instrument (Optical Spectro-P...ons that have never been seen before - including m...s skin lesions and were awaiting surgery for their...
Breaking Medicine News(10 mins):Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 2Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 3Health News:Harm Reduction for Alcohol: An Idea Whose Time Has Arrived 2Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 2Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 3Health News:New device enables early detection of cancerous skin tumors -- Ben Gurion U. 2
...you to cast a ballot, study suggests , , T...polls on Nov. 4? If so, your genes may be driving...ch as 50 percent of whether you vote or not may be...an family political history. , "Both nature and nu...
...The following is a,statement by Christine James-Br...hat Congress has taken the authority and opportuni...nd Targeted Case Management,(TCM) rules, as well a...d and clear statement that it is wrong to,target t...
...frastructure Helps Spanish Health Administrator, ...ngoing IT Development ...Inc.,(Nasdaq: TIBX ) today announced that the hea...alud (SERIS) will link,together a range of applica...
... ETHICON, Inc., a Johnson &,Johnson company, toda...tional offer from One Equity Partners to acquire t...cted a competitive bidding process to,prepare for ...One Equity Partners. The Professional Wound Care b...
... The Compassionate Friends self-help support org...rieving process following the death of a child is ... Nashville, Tennessee. More than 1300 parents, sib...more than 100 workshops covering most aspects of g...
... Professional Services, Information Security and ...Class Framework, DALLAS, July 1 The Health Infor...at it is on target to deliver the first-ever,Commo...curity specialists, liability insurers and other,o...
Other Medicine News:Health News:Genes Get Out the Vote 2Health News:Genes Get Out the Vote 3Health News:Statement by Christine James-Brown, President and CEO, Child Welfare League of America (CWLA) Re: Moratorium on Medicaid Regulations 2Health News:Rioja Hospital Uses TIBCO Software to Improve Customer Care and Streamline Operations 2Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 2Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 3Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 4Health News:Families Mourning Children Travel to Nashville for July Compassionate Friends National Conference 2Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 2Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 3Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 4Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 5
...oductivity, and proven reliability, Sorvall offers...g and centrifugation system that offers you a fast...e digital readouts, easy-to-operate touch controls...reliability, based on 40 years of proven performan...
MIC-D Digital Microscope
KR 4.22 Programmable Refrigerated Floor Model Centrifuge.
... programmable high and low speed refrigerated cent...LOCK JOUAN patented system, comprehensive control ..., Lifetime reproducibility, individual password pr... rates (100 run profiles), powerful refrigeration ...
Medicine Products: